Founded by a team of world-class scientists returning to China who have been selected for the Chinese “National Thousand Talents Program”, Clover Biopharmaceuticals is passionate about developing transformative biologic therapies for the millions of Chinese patients who currently do not have access to modern biological medicines. Seeking to Change the Paradigm in China | Emerging only recently from the advent of modern biotechnology, biologics today represent the majority of the world’s most efficacious therapies due to their high target specificity and lower off-target toxicities compared to small molecule drugs. In fact, biologics generated over US$150 billion in global sales and represented over 70% of the combined sales from the top 10 drugs worldwide in 2015. However, few of these therapies are approved in China, and most Chinese people are not able to access them at affordable prices. Clover is seeking to change this paradigm. Decades of Biologics Development & Manu...